secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2026-06-04T20:30:57+00:00
Accession:  0001062993-26-003060
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma shareholders approve up to 50:1 reverse stock split at special meeting
--------------------------------------------------------------------------------

- Ratified KPMG as auditor for FY 2026: 28,308,860 for, 756,378 withhold.
- All nine director nominees elected; broker non-votes of 13,529,765 per nominee.
- Special resolution for reverse share split up to 50:1 passed with 26,729,776 for, 2,335,461 against.
- Board now authorized to implement consolidation if deemed necessary for listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299326003060/0001062993-26-003060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299326003060/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-26-003060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer